Product Reports Resources Pricing Login Book a demo

Elligo Health Research

Biotech & Life Sciences · Austin, United States · Founded 2016

Direct access to over 150 million known patients and their healthcare data

Talent graph

Elligo Health Research's talent

Book a demo to see the people
Employees mapped 223 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 19 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

12 investors on Elligo Health Research's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Shumway Capital
Series B+ 11 investors entered at this stage
Noro-Moseley Partners
Piper Sandler
Hatteras Venture Partners
Morgan Stanley Expansion Capital
Piper Jaffray Private Capital Group
Norwest Venture Partners
Excelerate Health Ventures
Ally Bridge Group
FS Healthcare
Cerner (Formerly PGI & Associates)
Syneos Health

Global footprint

Where Elligo Health Research has talent and traffic

Workforce by country
🇺🇸 United States · Austin HQ
Book a demo for the full country breakdown
Web traffic by country
2.3K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

Capital deployed

Elligo Health Research's 3 investments and acquisitions.

Every disclosed deal where Elligo Health Research appeared as a backer or acquirer, 2018–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Elligo Health Research's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Elligo Health Research's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Elligo Health Research

        An AI-synthesized read of the highest-engagement posts about Elligo Health Research on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Elligo Health Research on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.